Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Jack Siegel

Adult Reconstructive Orthopaedic Surgery Virginia Beach, VA Medical Doctor

NPI 1770512006 CMS profile 307300

5716 Cleveland St, Suite 200, Virginia Beach, VA 23462

Open in the dashboard

General payments

$4,471

34 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Jack Siegel of Virginia Beach, VA is reported in the CMS Open Payments database as having received $4,471 across 34 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 33rd percentile of Adult Reconstructive Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $26 1
2023 General $989 10
2022 General $56 3
2019 General $3,400 20

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Jack Siegel
  • Adult Reconstructive Orthopaedic Surgery median
  • Middle half of Adult Reconstructive Orthopaedic Surgery
  • National median

In program year 2025, general payments to Jack Siegel were reported at $26. Among 1,079 Adult Reconstructive Orthopaedic Surgery profiles paid that year, the median was $1,406 and the middle half received between $318 and $8,709.

Show as a table
Year Jack Siegel Adult Reconstructive Orthopaedic Surgery median Middle half National median
2019 $3,400 $1,416 $292–$9,336 $163
2020 $0 $647 $141–$6,474 $114
2021 $0 $1,073 $211–$6,497 $132
2022 $56 $1,217 $236–$6,299 $149
2023 $989 $1,082 $246–$6,818 $160
2024 $0 $1,575 $323–$8,944 $164
2025 $26 $1,406 $318–$8,709 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Arthrex, Inc. $3,292 19 payments
  2. Fortis Surgical, LLC $670 4 payments
  3. Supreme Orthopedic Systems, LLC $195 1 payment
  4. DePuy Synthes Sales Inc. $174 2 payments
  5. Fidia Pharma USA Inc. $41 2 payments
  6. Zimmer Biomet Holdings, Inc. $37 2 payments
  7. Medical Device Business Services, Inc. $19 1 payment
  8. Flexion Therapeutics, Inc. $18 1 payment
  9. Ferring Pharmaceuticals Inc. $13 1 payment
  10. Sanofi-Aventis U.S. LLC $12 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Education $2,243 2 payments
  2. Travel and Lodging $1,501 6 payments
  3. Food and Beverage $727 26 payments
Products named General payments · program years 2019–2025
  1. ATTUNE $174 2 payments
  2. ARTHROPLASTY IMPLANTS SHOULDER ARTHROPLASTY & FRACTURE REVERS $85 1 payment
  3. HYMOVIS $41 2 payments
  4. mymobility Platform $20 1 payment
  5. Zilretta $18 1 payment
  6. ROSA $17 1 payment
  7. EUFLEXXA $13 1 payment
  8. SYNVISC-ONE $12 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 8 drugs

Part D claims

298

Median for Orthopedic Surgery: 203

Drug cost

$2,295

Median for Orthopedic Surgery: $1,433

Branded share of claims

0%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Diclofenac Sodium Generic 103 $923
Celecoxib Generic 35 $792
Oxycodone Hcl Generic 31 $175
Pregabalin Generic 14 $133
Ondansetron Hcl Generic 22 $112
Tramadol Hcl Generic 30 $86
Meloxicam Generic 46 $60
Amoxicillin Generic 17 $13

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 40 billing codes

Paid by Medicare

$326,222

Of which drugs: $15,284

Medicare patients

728

Average age 75

Services billed

9,586

418 women, 310 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Diabetes 31%
Depression 24%
Ischemic heart disease 22%
Chronic kidney disease 22%
Cancer 17%
Osteoporosis 16%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Hyaluronan or derivative, gel-one, for intra-articular injection, per dose J7326 Office 11 16 $6,655
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 438 6,214 $4,493

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

34 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Adult Reconstructive Orthopaedic Surgery in Virginia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record